Evaluation of common unfavourable genetic variants in cerebrovascular diseases: Recommendation for supportive genetic examinations and methodological approaches for common genetic variants

Current Medicinal Chemistry

Volumn 16, Issue 24, 2009, Pages 3168-3173

  Szolnoki, Zoltán ^a  

^a Department of Neurology and Neurophysiology   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

KINESIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; GENE ACTIVITY; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LEUKOARAIOSIS; LIGHT CHAIN; MULTIINFARCT DEMENTIA; REVIEW; GENETIC PREDISPOSITION; GENETICS; STROKE;

CEREBROVASCULAR DISORDERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LEUKOARAIOSIS; POLYMORPHISM, GENETIC; STROKE;

EID: 70350719370     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788803006     Document Type: Review

References (70)

1. Dichgans, M. Genetics of ischaemic stroke. Lancet Neurol., 2007, 6, 149-161
2. Szolnoki, Z.; Melegh, B. Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis. Curr. Med. Chem., 2006, 13, 1627-1634
3. Pantoni, L.; Poggesi, A.; Inzitari, D. The relation between white-matter lesions and cognition. Curr. Opin. Neurol., 2007, 20, 390-397
4. Baezner, H.; Blahak, C.; Poggesi, A.; Pantoni, L.; Inzitari, D.; Chabriat, H.; Erkinjuntti, T.; Fazekas, F.; Ferro, J.M.; Langhorne, P.; O'Brien, J.; Scheltens, P.; Visser, M.C.; Wahlund, L.O.; Waldemar, G.; Wallin, A.; Hennerici, M.G.; LADIS Study Group. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology, 2008, 70, 935-942
5. Censori, B.; Partziguian, T.; Manara, O.; Poloni, M. Plasma homocysteine and severe white matter disease. Neurol. Sci., 2007, 28, 259-263 (Pubitemid 350055435)
6. Naka, H.; Nomura, E.; Takahashi, T. Plasma total homocysteine levels are associated with advanced leukoaraiosis but not with asymptomatic microbleeds on T2*-weighted MRI in patients with stroke. Eur. J. Neurol., 2006, 13, 261-265
7. Sachdev, P.; Parslow, R.; Salonikas, C. Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men. Arch. Neurol., 2004, 61, 1369-1376
8. Clarke, R.; Joachim, C.; Esiri, M.; Morris, J.; Bungay, H.; Molyneux, A.; Budge, M.; Frost, C.; King, E.; Barnetson, L.; Smith, A.D. Leukoaraiosis at presentation and disease progression during follow-up in histologically confirmed cases of dementia. Ann. N.Y. Acad. Sci., 2000, 903, 497-500.
9. Hogervorst, E.; Ribeiro, H.M.; Molyneux, A.; Budge, M.; Smith, A.D. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch. Neurol., 2002, 59, 787-793
10. Szolnoki, Z.; Somogyvári, F.; Kondacs. A. Evaluation of the roles of common genetic mutations in leukoaraiosis. Acta Neurol. Scand., 2001, 104, 281-287 (Pubitemid 32977148)
11. Szolnoki, Z. Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromol. Med., 2007, 9, 21-34. (Pubitemid 44772273)
12. Szolnoki, Z. Chemical events behind leukoaraiosis: medicinal chemistry offers new insight into a specific microcirculation disturbance in the brain (a chemical approach to a frequent cerebral phenotype). Curr. Med. Chem., 2007, 14, 1027-1036 (Pubitemid 46672637)
13. Markus, H.S. Genes, endothelial function and cerebral small vessel disease in man. Exp. Physiol., 2008, 93, 121-127
14. Szolnoki, Z.; Kondacs, A.; Mandi, Y.; Somogyvari, F. A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interactions behind vascular white matter demyelinization. J. Mol. Neurosci., 2007, 33, 173-179 (Pubitemid 47574940)
15. Szolnoki, Z. Genetic variant-associated endothelial dysfunction behind small-vessel cerebral circulatory disorders: a new pathomechanism behind common cerebral phenotypes. Mini Rev. Med. Chem., 2007, 7, 527-530 (Pubitemid 46845800)
16. Szolnoki, Z. Evaluation of the interactions of common genetic mutations in stroke. Methods Mol. Med., 2005, 104, 241-250
17. De Ciuceis, C.; Amiri, F.; Brassard, P.; Endemann, D.H.; Touyz, R.M.; Schiffrin, E.L. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 2106-2113
18. Watanabe, S.; Tagawa, T.; Yamakawa, K.; Shimabukuro, M.; Ueda, S. Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 2376-2380 (Pubitemid 41552657)
19. Cameron, V.A.; Mocatta, T.J.; Pilbrow, AP.; Frampton, C.M.; Troughton, R.W.; Richards, A.M.; Winterbourn, C.C. Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension, 2006, 47, 1155-1161
20. Szolnoki, Z.; Maasz, A.; Magyari, L.; Horvatovich, K.; Farago, B.; Somogyvari, F.; Kondacs, A.; Szabo, M.; Bodor, A.; Hadarits, F.; Melegh, B. The combination of homozygous MTHFR 677T and angiotensin II type-1 receptor 1166C variants confers the risk of small-vessel-associated ischemic stroke. J. Mol. Neurosci., 2007, 31, 201-207 (Pubitemid 47338414)
21. Szolnoki, Z.; Maasz, A.; Magyari, L.; Horvatovich, K.; Farago, B.; Somogyvari, F.; Kondacs, A.; Szabo, M.; Fodor, L.; Bodor, A.; Hadarits, F.; Melegh, B. Coexistence of angiotensin II type-1 receptor A1166C and angiotensin-converting enzyme D/D polymorphism suggests susceptibility for small-vessel-associated ischemic stroke. Neuromol. Med., 2006, 8, 353-360 (Pubitemid 43918156)
22. Henskens, L.H.; Kroon, A.A.; van der Schouw, Y.T.; Schiffers, P.M.; Grobbee, D.E.; de Leeuw, P.W.; Bots, M.L. Reninangiotensin system and nitric oxide synthase gene polymorphisms in relation to stroke. Am. J. Hypertens, 2007, 20, 764-770 (Pubitemid 46951020)
23. Brenner, D.; Labreuche, J.; Poirier, O.; Cambien, F.; Amarenco, P.; GENIC Investigators. Renin-angiotensin-aldosterone system in brain infarction and vascular death. Ann. Neurol., 2005, 58,131-138
24. van Rijn, M.J.; Bos, M.J.; Isaacs, A.; Yazdanpanah, M.; Arias- Vásquez, A.; Stricker, B.H.; Klungel, O.H.; Oostra, B.A.; Koudstaal, P.J.; Witteman, J.C.; Hofman, A.; Breteler, M.M.; van Duijn, C.M. Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J. Neurol. Neurosurg. Psychiatry, 2007, 78, 1083-1087
25. Möllsten, A.; Stegmayr, B.; Wiklund, P.G. Genetic polymorphisms in the renin-angiotensin system confer increased risk of stroke independently of blood pressure: a nested case-control study. J. Hypertens, 2008, 26, 1367-1372
26. Welch, G.N. Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med., 1998, 338, 1042-1050
27. Bersano, A.; Ballabio, E.; Bresolin, N.; Candelise, L. Genetic polymorphisms for the study of multifactorial stroke. Hum. Mutat., 2008, 29, 776-795 (Pubitemid 351794129)
28. Pezzini, A.; Grassi, M.; Del Zotto, E.; Giossi, A.; Monastero, R.; Dalla, Volta. G.; Archetti, S.; Zavarise, P.; Camarda, C.; Gasparotti, R.; Magoni, M.; Camarda, R.; Padovani, A. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke, 2007, 38, 3145-3151 (Pubitemid 350175728)
29. Cronin, S.; Furie, K.L.; Kelly, P.J. Dose-Related Association of MTHFR 677T Allele With Risk of Ischemic Stroke. Stroke, 2005, 36, 1581-1587.
30. Choi, B.O.; Kim, N.K.; Kim, S.H.; Kang, M.S.; Lee, S.; Ahn, J.Y. Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thrombosis Res., 2003, 111, 39-44.
31. Helenius, J.Treatment of Leukoaraiosis: a futuristic view. Curr. Drug Targets, 2007, 8, 839-845.
32. Hentschel, F.; Kölsch, H. The Molecular Genetics of the Risk Factors of Vascular Dementias. Clin. Neuroradiol., 2007, 17, 23-29. (Pubitemid 46364918)
33. Andresen, J.; Shafi, N.I.; Bryan, R.M. Jr. Endothelial influences on cerebrovascular tone. J. Appl. Physiol., 2006, 100, 318-327
34. Hassan, A.; Hunt, B.J.; O'Sullivan, M.; Bell, R.; D'Souza, R.; Jeffery, S.; Bamford, J.M.; Markus, H.S. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain, 2004, 127, 212-219
35. Hingorani, A.D. Endothelial nitric oxide synthase polymorphisms and hypertension. Curr. Hypertens Rep., 2003, 5, 19-25. (Pubitemid 38898928)
36. Henskens, L.H.; Kroon, A.A.; van Boxtel, M.P.; Hofman, P.A.; de Leeuw, P.W. Associations of the angiotensin II type 1 receptor A1166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension. Stroke, 2005, 36, 1869-1873
37. Szolnoki, Z.; Havasi, V.; Bene, J.; Komlósi, K.; Szöke, D.; Somogyvári, F.; Kondacs, A.; Szabó, M.; Fodor, L.; Bodor, A.; Gáti, I.; Wittman, I.; Melegh, B. Endothelial nitric oxide synthase gene interactions and the risk of ischaemic stroke. Acta Neurol. Scand., 2005, 111, 29-33.
38. Berger, K.; Stögbauer, F.; Stoll, M.; Wellmann, J. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum. Genet., 2007, 121, 169-178. (Pubitemid 46404451)
39. Lam, A.; Hamilton-Bruce, M.A.; Jannes, J.; Koblar, S.A. Cerebral Small Vessel Disease: Genetic Risk Assessment for Prevention and Treatment. CNS Disord. Mol. Diagnosis Ther., 2008, 12, 145-156.
40. Casas, J.P.; Cavalleri, G.L.; Bautista, L.E.; Smeeth, L. Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review. Am. J. Epidemiol., 2006, 164, 921-935.
41. Cheng, J.; Liu, J.; Li, X.; Yu, L.; Peng, J.; Zhang, R. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: A case-control study in a Chinese population. Clin. Chim. Acta, 2008, 392, 46-51.
42. Amar, K.; MacGowan, S.; Wilcock, G.; Lewis, T.; Scott, M. Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population. Int. J. Geriatr. Psychiatry, 1998, 13, 585-590 (Pubitemid 28441957)
43. Hassan, A.; Lansbury, A.; Catto, A.J.; Guthrie, A.; Spencer, J.; Craven, C.; Grant, P.J.; Bamford, J.M. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J. Neurol. Neurosurg. Psychiatry, 2002, 72, 343-346 (Pubitemid 34185203)
44. Sierra, C.; Coca, A.; Gómez-Angelats, E.; Poch, E.; Sobrino, J.; de la Sierra, A. Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension. Hypertension, 2002, 39, 343-347 (Pubitemid 34165146)
45. Szolnoki, Z.; Somogyvári, F.; Kondacs, A. Evaluation of the interaction of common genetic mutations in stroke subtypes. J. Neurol., 2002, 249, 1391-1397 (Pubitemid 35217660)
46. Szolnoki, Z.; Somogyvári, F.; Kondacs, A. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke. J. Neurol. Neurosurg. Psychiatry, 2003, 74, 1615-1620 (Pubitemid 37542048)
47. Hong, S.H.; Park, H.M.; Ahn, J.Y.; Kim, O.J.; Hwang, T.S.; Oh, D.; Kim, N.K. ACE I/D polymorphism in Korean patients with ischemic stroke and silent brain infarction. Acta Neurol. Scand., 2008, 117, 244-249
48. Pezzini, A.; Grassi, M.; Zotto, E.D.; Archetti, S. Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults. Stroke, 2005, 36, 533-539 (Pubitemid 40344152)
49. Purandare, N.; Oude, Voshaar, R.C.; Davidson, Y. Deletion/ Insertion Polymorphism of the Angiotensin-Converting Enzyme Gene and White Matter Hyperintensities in Dementia: A Pilot Study. J. Am. Geriatr. Soc., 2006, 54, 1395-1400 (Pubitemid 44342890)
50. Szolnoki, Z.; Havasi, V.; Talián, G.; Bene, J.; Komlósi, K.; Somogyvári, F.; Kondacs, A.; Szabó, M.; Fodor, L.; Bodor, .; Melegh, B. Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke. J. Mol. Neurosci., 2005, 27, 205-211
51. Trompet, S.; de Craen, A.J.; Slagboom, P.; Shepherd, J.; Blauw, G.J.; Murphy, M.B.; Bollen, E.L.; Buckley, B.M.; Ford, I.; Gaw, A.; Macfarlane, P.W.; Packard, C.J.; Stott, D.J.; Westendorp, R.G.; Jukema, J.W.; on behalf of the PROSPER Group. Lymphotoxinalpha C804A polymorphism is a risk factor for stroke. The PROSPER study. Exp. Gerontol., 2008, 43, 801-805
52. Liu, Y.; Herrington, D.; Burdon, K.P.; Langefeld, C.D.; Rich, S.S.; Bowden, D.W.; Freedman, B.I.; Wagenknecht, L.E. A functional polymorphism in the lymphotoxin-alpha gene is associated with carotid artery wall thickness: the Diabetes Heart Study. Eur. J. Cardiovasc. Prev. Rehabil., 2006, 13, 655-657
53. Yamasaki, Y.; Katakami, N.; Sakamoto, K.; Kaneto, H.; Matsuhisa, M.; Sato, H.; Hori, M.; Haneda, M.; Kashiwagi, A.; Tanaka. Y.; Kawamori, R.; Kuno, S. Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes. Diabetes Care, 2006, 29, 2445-2451 (Pubitemid 44912250)
54. Abboud, S.; Viiri, L.E.; Lütjohann, D.; Goebeler, S.; Luoto, T.; Friedrichs, S.; Desfontaines, P.; Gazagnes, M.D.; Laloux, P.; Peeters, A.; Seeldrayers, P.; Lehtimaki, T.; Karhunen, P.; Pandolfo, M.; Laaksonen, R. Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis. Eur. J. Hum. Genet., 2008, 16, 955-960
55. Tzourio, C.; Arima, H.; Harrap, S.; Anderson, C.; Godin, O.; Woodward, M.; Neal, B.; Bousser, M.G.; Chalmers, J.; Cambien, F.; MacMahon, S. APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology, 2008, 70, 1322-1328 (Pubitemid 351550353)
56. Saidi, S.; Slamia, L.B.; Ammou, S.B.; Mahjoub, T.; Almawi, W.Y. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. J. Stroke Cerebrovasc. Dis., 2007, 16, 160-166
57. Szolnoki, Z.; Somogyvári, F.; Kondacs, A.; Szabó, M.; Fodor, L.; Bene, J.; Melegh, B. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis. Acta Neurol. Scand., 2004, 109, 222-227 (Pubitemid 38270880)
58. Wen, H.M.; Baum, L.; Cheung, W.S.; Mok, V.; Lam, W.W.; Tomlinson, B.; Wong, K.S.; Ng, H.K. Apolipoprotein E ε4 allele is associated with the volume of white matter changes in patients with lacunar infarcts. Eur. J. Neurol., 2006, 13, 1216-1220
59. Andersson, M.E.; Sjölander, A.; Andreasen, N.; Minthon, L.; Hansson, O.; Bogdanovic, N.; Jern, C.; Jood, K.; Wallin, A.; Blennow, K.; Zetterberg, H. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease. Int. J. Mol. Med., 2007a, 20, 233-239
60. Andersson, M.E.; Zetterberg, M.; Tasa, G.; Seibt-Palmér, M.; Juronen, E.; Teesalu, P.; Blennow, K.; Zetterberg, H. Variability in the kinesin light chain 1 gene may influence risk of age-related cataract. Mol. Vis., 2007b, 13, 993-996 (Pubitemid 47007421)
61. Dhaenens, C.M.; Van Brussel, E.; Schraen-Maschke, S.; Pasquier, F.; Delacourte, A.; Sablonniere, B. Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neurosci. Lett., 2004, 368, 290-292 (Pubitemid 39214970)
62. Szolnoki, Z.; Kondacs, A.; Mandi, Y.; Somogyvari, F. A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the janus face of the kinesin light-chain 1 56836CC genetic variant. Neuromol. Med., 2007, 9, 335-339 (Pubitemid 350242637)
63. Szolnoki, Z.; Kondacs, A.; Mandi, Y.; Somogyvari, F. Evaluation of the roles of the A185C and C406T kinesin light-chain 1 variants in the development of leukoaraiosis. Neurosci. Lett., 2007, 429, 101-104 (Pubitemid 350161115)
64. Szolnoki, Z.; Somogyvári, F.; Szólics, M.; Szabó, M.; Fodor, L. Common genetic mutations as possible aetiological factors in stroke. Eur. Neurol., 2001, 45, 119-120 (Pubitemid 32215800)
65. Szolnoki, Z. Reduced noncovalent connections in leukoaraiosis. Expert Rev. Neurother., 2008, 8, 205-213
66. Szolnoki, Z. A dynamically changing intracellular water network serves as a universal regulator of the cell: the water-governed cycle. Biochem. Biophys. Res. Commun., 2007, 357, 331-334 (Pubitemid 46628903)
67. Guang, Yong Zou. The merits if testing Hardy-Weinberg Equilibrium in the analysis of unmatched case-control data: a cautionary note. Ann. Hum. Genet., 2006, 70, 923-933
68. Shoemaker, J. A Bayesian characterization of Hardy-Weinberg disequilibrium. Genetics, 1998, 149, 2079-2088
69. Nielsen, D.M. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am. J. Hum. Genet., 1998, 63, 1531-1540 (Pubitemid 30418550)
70. Szolnoki, Z.; Kondacs, A.; Mandi, Y.; Somogyvari, F. Geneenvironmental effects behind leukoaraiosis: a silent genetic variant of the kinesin protein can be activated in a subject with poorly controlled long-lasting hypertension. Clin. Biochem., 2009, 42, 630-633